Nsclc Cells | List of Frontiers open access articles

Original Research

Published on 21 Jan 2026

Pemetrexed sensitizes cisplatin therapy by inducing ferroptosis in NSCLC cells

in Pharmacology of Anti-Cancer Drugs

Yumin Wang
Xin Zhang
Yuwei Cao
Ge Zhang
Yonglin Zhu
Yulin Li
Jichao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1764937

1,037 views
1 citation

Original Research

Published on 29 Nov 2017

Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

in Cancer Molecular Targets and Therapeutics

Hongjian Li
Christy Wing-Sum Tong
Yee Leung
Man-Hon Wong
Kenneth Kin-Wah To
Kwong-Sak Leung

Frontiers in Oncology

doi 10.3389/fonc.2017.00288

7,766 views
30 citations

Original Research

Published on 10 Feb 2023

FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance

in Molecular and Cellular Oncology

Feng Ma
Xinhai Zhu
Yuchun Niu
Aitao Nai
Shoaib Bashir
Yan Xiong
Yunlong Dong
Yin Li
Jian Song
Meng Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1088444

4,713 views
4 citations

Original Research

Published on 27 Jul 2021

RETRACTED: A Novel Tumor Suppressor Gene, ZNF24, Inhibits the Development of NSCLC by Inhibiting the WNT Signaling Pathway to Induce Cell Senescence

in Molecular and Cellular Oncology

Bo Pang
Yong Wang
Xiaoyan Chang

Frontiers in Oncology

doi 10.3389/fonc.2021.664369

4,047 views
6 citations

Original Research

Published on 10 Dec 2019

Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205

in Cancer Immunity and Immunotherapy

Yong Lu
Wenlong Xu
Yanli Gu
Xu Chang
Guojian Wei
Zhien Rong
Li Qin
Xiaoping Chen
Fang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2019.02829

7,542 views
24 citations

Original Research

Published on 07 May 2021

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression

in Cancer Molecular Targets and Therapeutics

Hu Cai
Lili Ren
Ying Wang
Yongjun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.571476

3,772 views
14 citations

Original Research

Published on 13 Nov 2025

Circ_0060927 regulates miR-331-3p/ERK/MAPK pathway reaction in non-small cell lung cancer through METTL14-driven methylation

in Cancer Cell Signaling

Yang Liao
Ji Song
Chun Luo
Jin Xiang
Sheng Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1609215

1,180 views

Original Research

Published on 14 Jun 2021

Tumor Cell-Derived Exosomal miR-770 Inhibits M2 Macrophage Polarization via Targeting MAP3K1 to Inhibit the Invasion of Non-small Cell Lung Cancer Cells

in Molecular and Cellular Oncology

Jixian Liu
Ruixing Luo
Junbin Wang
Xinyu Luan
Da Wu
Hua Chen
Qinghua Hou
Guangxian Mao
Xiaoqiang Li

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.679658

6,533 views
52 citations

Original Research

Published on 09 Jul 2018

Gossypol Inhibits Non-small Cell Lung Cancer Cells Proliferation by Targeting EGFRL858R/T790M

in Experimental Pharmacology and Drug Discovery

Yuwei Wang
Huanling Lai
Xingxing Fan
Lianxiang Luo
Fugang Duan
Zebo Jiang
Qianqian Wang
Elaine Lai Han Leung
Liang Liu
Xiaojun Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00728

6,051 views
29 citations

Original Research

Published on 29 Aug 2022

S-3′-hydroxy-7′, 2′, 4′-trimethoxyisoxane, a novel ferroptosis inducer, promotes NSCLC cell death through inhibiting Nrf2/HO-1 signaling pathway

in Pharmacology of Anti-Cancer Drugs

Jing Chen
Songlin Zhou
Xian Zhang
Huange Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973611

4,438 views
18 citations

Original Research

Published on 19 Mar 2021

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway

in Molecular and Cellular Oncology

Huiqing Yu
Ling Tian
Liejun Yang
Shihong Liu
Sixiong Wang
Juan Gong

Frontiers in Oncology

doi 10.3389/fonc.2021.620213

4,638 views
19 citations

Original Research

Published on 14 Mar 2024

Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells

in Cancer Immunity and Immunotherapy

Yutao Li
Amit Sharma
Michèle J. Hoffmann
Dirk Skowasch
Markus Essler
Hans Weiher
Ingo G. H. Schmidt-Wolf

Frontiers in Immunology

doi 10.3389/fimmu.2024.1268652

7,761 views
12 citations

Original Research

Published on 02 Jun 2022

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Federica Francescangeli
Maria Laura De Angelis
Rachele Rossi
Giovanni Sette
Adriana Eramo
Alessandra Boe
Ombretta Guardiola
Tao Tang
Shi-Cang Yu
Gabriella Minchiotti

Frontiers in Oncology

doi 10.3389/fonc.2022.830873

4,457 views
6 citations

Original Research

Published on 21 Jun 2021

Analysis of Long Noncoding RNAs in Aila-Induced Non-Small Cell Lung Cancer Inhibition

in Pharmacology of Anti-Cancer Drugs

Lin Chen
Cui Wu
Heming Wang
Sinuo Chen
Danhui Ma
Ye Tao
Xingye Wang
Yanhe Luan
Tiedong Wang
Yan Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.652567

4,322 views
8 citations

Original Research

Published on 16 Apr 2018

The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest

in Pharmacology of Anti-Cancer Drugs

Chan-Woo Park
Yesol Bak
Min-Je Kim
Ganipisetti Srinivasrao
Joonsung Hwang
Nak K. Sung
Bo Yeon Kim
Jae-Hyuk Yu
Jin Tae Hong
Do-Young Yoon

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00163

6,261 views
15 citations

Original Research

Published on 06 Oct 2022

MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3

in Molecular and Cellular Oncology

Shasha Zhu
Xiangbing Kong
Mengru Song
Mingyang Chi
Yitong Liu
Peng Zhang
Qiao Zhang
Pingping Shang
Feifei Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.985962

4,492 views
17 citations

Articles

Pemetrexed sensitizes cisplatin therapy by inducing ferroptosis in NSCLC cells

Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance

RETRACTED: A Novel Tumor Suppressor Gene, ZNF24, Inhibits the Development of NSCLC by Inhibiting the WNT Signaling Pathway to Induce Cell Senescence

Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression

Circ_0060927 regulates miR-331-3p/ERK/MAPK pathway reaction in non-small cell lung cancer through METTL14-driven methylation

Tumor Cell-Derived Exosomal miR-770 Inhibits M2 Macrophage Polarization via Targeting MAP3K1 to Inhibit the Invasion of Non-small Cell Lung Cancer Cells

Gossypol Inhibits Non-small Cell Lung Cancer Cells Proliferation by Targeting EGFRL858R/T790M

S-3′-hydroxy-7′, 2′, 4′-trimethoxyisoxane, a novel ferroptosis inducer, promotes NSCLC cell death through inhibiting Nrf2/HO-1 signaling pathway

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway

Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

Analysis of Long Noncoding RNAs in Aila-Induced Non-Small Cell Lung Cancer Inhibition

The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest

MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3